HomeEYPT • NASDAQ
add
Eyepoint Pharmaceuticals Inc
Previous close
$16.72
Day range
$16.59 - $17.74
Year range
$3.91 - $17.74
Market cap
1.46B USD
Avg Volume
1.26M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 966.00K | -90.82% |
Operating expense | 15.53M | 11.23% |
Net income | -59.73M | -103.44% |
Net profit margin | -6.18K | -2,116.37% |
Earnings per share | -0.85 | -57.41% |
EBITDA | -61.45M | -90.01% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 204.02M | -19.61% |
Total assets | 251.70M | -16.36% |
Total liabilities | 51.51M | -37.32% |
Total equity | 200.18M | — |
Shares outstanding | 82.79M | — |
Price to book | 5.81 | — |
Return on assets | -56.10% | — |
Return on capital | -62.88% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -59.73M | -103.44% |
Cash from operations | -59.35M | -52.08% |
Cash from investing | 55.38M | 241.97% |
Cash from financing | 7.40M | -37.75% |
Net change in cash | 3.43M | 131.39% |
Free cash flow | -38.27M | -38.52% |
About
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems and nanotechnology to drug delivery.
pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency. QinetiQ continues to be a strategic partner.
In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc. Wikipedia
Founded
1987
Headquarters
Website
Employees
165
